| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/21/1999 | US5955269 Methods of screening foods for nutraceuticals |
| 09/21/1999 | US5955268 Detecting target in sample by amplification, then hybridization to labeled capture prodes immobilized on support, detecting change in signal |
| 09/21/1999 | US5955264 Rapid and simple selection of complementary dna encoding proteinmutations which reduce binding; using expression vectors in host cells exposed to selection agents |
| 09/21/1999 | US5955263 Detecting wild type human oncogene protein in cell; diagnosis and cancer treatment; anticarcinogenic agents |
| 09/21/1999 | US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample |
| 09/21/1999 | US5955258 Using homologous and heterologous proteolytic enzymes from gram positive lactobacillus to disrupt bacterial cell in culture; bactericides; to prevent food spoilage and improving self life;food processing of cheese |
| 09/21/1999 | US5955137 Proteins with amino acid sequences and enzyme source |
| 09/21/1999 | US5955090 Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins |
| 09/21/1999 | US5955089 Streptococcus for vaccines |
| 09/21/1999 | US5955088 Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins |
| 09/21/1999 | US5955087 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| 09/21/1999 | US5955073 Selective RNase cytotoxic reagents |
| 09/21/1999 | US5955072 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
| 09/21/1999 | US5955069 Use of canine interferon-γ(IFN-γ) to treat non-atopic dermatitis |
| 09/21/1999 | US5955059 Treating psoriasis, other skin disorders |
| 09/21/1999 | US5955056 Assay for monitoring and assessing the mutagenic potential of agents which involves creating transgenic non-human animals carrying a test dna sequence or sequences that can be quickly recovered and examined for mutations following exposure to one |
| 09/21/1999 | CA2194960C Cleavage of 5.alpha.-reductase mrna |
| 09/21/1999 | CA2181189C Mesoscale polynucleotide amplification devices |
| 09/21/1999 | CA2174971C Neural axon outgrowth modulators |
| 09/21/1999 | CA2098773C Recombinant coccidia and its use in a vaccine |
| 09/21/1999 | CA2087703C Binary cryptocytotoxic method of hybrid seed production |
| 09/21/1999 | CA2063427C Rapid, versatile and simple system for expressing genes in eukaryotic cells |
| 09/21/1999 | CA2016841C A method for producing polymers having a preselected activity |
| 09/21/1999 | CA1340762C Recombinant birth control vaccine |
| 09/21/1999 | CA1340761C Interleukin-4-receptors |
| 09/20/1999 | CA2232812A1 Interleukin-1 receptor antagonist beta (il-1ra.beta.) |
| 09/16/1999 | WO1999046597A1 Assay of igfbp complex |
| 09/16/1999 | WO1999046592A1 Regulation of the cell cycle by sterols |
| 09/16/1999 | WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/16/1999 | WO1999046408A1 Detection of neoplasia by analysis of saliva |
| 09/16/1999 | WO1999046400A1 Compositions and methods for enhanced synthesis of nucleic acid molecules |
| 09/16/1999 | WO1999046399A1 Enzymatic preparation of glucose syrup from starch |
| 09/16/1999 | WO1999046396A2 Glyphosate as a gametocide |
| 09/16/1999 | WO1999046395A1 Transgenic crops accumulating fructose polymers and methods for their production |
| 09/16/1999 | WO1999046394A1 Novel plant plastid promoter sequence |
| 09/16/1999 | WO1999046391A2 Prostate derived serine protease (pdsp) protein and nucleic acid molecules and uses therefor |
| 09/16/1999 | WO1999046390A1 Chitinase chitin-binding fragments |
| 09/16/1999 | WO1999046389A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase |
| 09/16/1999 | WO1999046388A1 Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna |
| 09/16/1999 | WO1999046387A1 Biosynthetic genes for spinosyn insecticide production |
| 09/16/1999 | WO1999046386A1 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5 |
| 09/16/1999 | WO1999046385A2 Compositions and methods for the treatment and prevention of metastatic disorders |
| 09/16/1999 | WO1999046384A2 Human smad3 and smad4 are sequence-specific transcription activators |
| 09/16/1999 | WO1999046383A1 Human n-type calcium channel isoform and uses thereof |
| 09/16/1999 | WO1999046382A1 Chondrosarcoma associated genes |
| 09/16/1999 | WO1999046381A2 Human fgf gene and gene expression products |
| 09/16/1999 | WO1999046380A2 Human membrane spanning proteins |
| 09/16/1999 | WO1999046379A2 Human receptor proteins; related reagents and methods |
| 09/16/1999 | WO1999046378A1 Novel g protein-coupled receptor proteins |
| 09/16/1999 | WO1999046377A2 A human vanilloid receptor-like cation channel |
| 09/16/1999 | WO1999046376A1 Receptor from the superfamily of tnt-receptors from the human lung |
| 09/16/1999 | WO1999046375A2 Human nucleic acid sequences from prostate tissue |
| 09/16/1999 | WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue |
| 09/16/1999 | WO1999046372A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
| 09/16/1999 | WO1999046371A2 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 09/16/1999 | WO1999046370A2 Expression of trehalose biosynthetic genes in plants |
| 09/16/1999 | WO1999046369A1 Novel dicarbonylreductase and gene encoding the same |
| 09/16/1999 | WO1999046364A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | WO1999046363A1 Transformed microorganisms with improved properties |
| 09/16/1999 | WO1999046362A1 Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase |
| 09/16/1999 | WO1999046361A1 Techniques for piercing specific site of cell |
| 09/16/1999 | WO1999046299A1 Improved methods for producing factor viii proteins |
| 09/16/1999 | WO1999046297A1 Mutants of monoamine oxidase b |
| 09/16/1999 | WO1999046296A1 Ecr673: a 7-transmembrane g-protein coupled receptor |
| 09/16/1999 | WO1999046295A1 A gene homologous to the drosophila b(2)gen gene and putative yeast 26.5kd protein ypr015c |
| 09/16/1999 | WO1999046294A1 A human chd-1 like gene |
| 09/16/1999 | WO1999046293A1 A zinc finger protein derived from hematopoietic cells |
| 09/16/1999 | WO1999046292A1 A human p18 gene (cbdara04) |
| 09/16/1999 | WO1999046291A1 A human glia maturation factor (gmf) beta homolog gene (cbfboe11) |
| 09/16/1999 | WO1999046290A1 A human angiotensin ii/vasopressin receptor (aii/avp) like gene (cbdakd01) |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046288A2 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 09/16/1999 | WO1999046287A1 Secreted proteins and polynucleotides encoding them |
| 09/16/1999 | WO1999046286A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 09/16/1999 | WO1999046284A2 Molecules that home to various selected organs or tissues |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999046282A1 Plasminogen-related gene b polypeptides |
| 09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | WO1999046277A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 09/16/1999 | WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS) |
| 09/16/1999 | WO1999046274A1 Modified factor viii |
| 09/16/1999 | WO1999046235A1 Fullerene derivatives |
| 09/16/1999 | WO1999046047A2 Detection and characterization of microorganisms |
| 09/16/1999 | WO1999045966A1 Polynucleotide composition, method of preparation, and use thereof |
| 09/16/1999 | WO1999045962A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 09/16/1999 | WO1999045959A1 Humanized antibody and uses thereof |
| 09/16/1999 | WO1999045954A1 Hla-binding peptides and their uses |
| 09/16/1999 | WO1999045951A2 Thy-1 expression in angiogenesis |
| 09/16/1999 | WO1999045767A1 Non-human transgenic mammal, method for producing same and its use |
| 09/16/1999 | WO1999038967A3 Recombinant proteins derived from hgf and msp |
| 09/16/1999 | WO1999037782A3 Frozen food product |
| 09/16/1999 | WO1999037763A3 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 09/16/1999 | WO1999037673A3 Antifreeze protein |
| 09/16/1999 | WO1999036511A3 Feline immunodeficiency virus gene therapy vectors |
| 09/16/1999 | WO1999035286A3 Assay for predicting the angiographic response to lipid-lowering therapy in patients |
| 09/16/1999 | WO1999035274A3 Nucleic acids encoding thermostable pullulanases |
| 09/16/1999 | WO1999035269A3 Method for controlling the division and/or elongation of eukariotic cells |
| 09/16/1999 | WO1999035243A3 Extension of cellular lifespan, methods and reagents |
| 09/16/1999 | WO1999035106A3 Mammalian edg-7 receptor homologs |
| 09/16/1999 | WO1999034823A3 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS |